End-of-day quote
Shanghai S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
1.97
CNY
|
-1.99%
|
|
+3.68%
|
-18.60%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,312
|
2,432
|
11,191
|
12,702
|
11,806
|
9,429
|
Enterprise Value (EV)
1 |
1,303
|
1,255
|
9,775
|
12,208
|
12,658
|
14,272
|
P/E ratio
|
43.1
x
|
44.3
x
|
20
x
|
19.5
x
|
14.4
x
|
-34.3
x
|
Yield
|
0.86%
|
0.98%
|
3.27%
|
4.6%
|
4.95%
|
-
|
Capitalization / Revenue
|
1.96
x
|
2.33
x
|
0.69
x
|
0.65
x
|
0.52
x
|
0.4
x
|
EV / Revenue
|
1.1
x
|
1.21
x
|
0.6
x
|
0.63
x
|
0.55
x
|
0.61
x
|
EV / EBITDA
|
10.9
x
|
9.31
x
|
6.24
x
|
8.59
x
|
7.64
x
|
54.3
x
|
EV / FCF
|
-28
x
|
6.58
x
|
-46.5
x
|
-14.1
x
|
-15.3
x
|
-3.97
x
|
FCF Yield
|
-3.57%
|
15.2%
|
-2.15%
|
-7.09%
|
-6.52%
|
-25.2%
|
Price to Book
|
1.77
x
|
1.81
x
|
1.95
x
|
1.95
x
|
1.75
x
|
1.5
x
|
Nbr of stocks (in thousands)
|
797,244
|
797,244
|
3,657,166
|
3,896,340
|
3,896,340
|
3,896,344
|
Reference price
2 |
2.900
|
3.050
|
3.060
|
3.260
|
3.030
|
2.420
|
Announcement Date
|
4/22/19
|
3/9/20
|
4/19/21
|
3/28/22
|
3/28/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,182
|
1,041
|
16,300
|
19,479
|
22,837
|
23,479
|
EBITDA
1 |
119.5
|
134.8
|
1,567
|
1,421
|
1,658
|
262.7
|
EBIT
1 |
77.46
|
96.67
|
865.1
|
763.8
|
1,034
|
-279.4
|
Operating Margin
|
6.55%
|
9.28%
|
5.31%
|
3.92%
|
4.53%
|
-1.19%
|
Earnings before Tax (EBT)
1 |
96.98
|
115.7
|
789.8
|
790.6
|
1,008
|
-380.8
|
Net income
1 |
53.63
|
54.93
|
559.1
|
629.7
|
818.2
|
-275
|
Net margin
|
4.54%
|
5.27%
|
3.43%
|
3.23%
|
3.58%
|
-1.17%
|
EPS
2 |
0.0673
|
0.0689
|
0.1529
|
0.1676
|
0.2100
|
-0.0706
|
Free Cash Flow
1 |
-46.5
|
190.8
|
-210.4
|
-865.6
|
-825.9
|
-3,598
|
FCF margin
|
-3.93%
|
18.32%
|
-1.29%
|
-4.44%
|
-3.62%
|
-15.32%
|
FCF Conversion (EBITDA)
|
-
|
141.48%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
347.25%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0250
|
0.0300
|
0.1000
|
0.1500
|
0.1500
|
-
|
Announcement Date
|
4/22/19
|
3/9/20
|
4/19/21
|
3/28/22
|
3/28/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
852
|
4,843
|
Net Cash position
1 |
1,009
|
1,176
|
1,416
|
494
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
0.5142
x
|
18.43
x
|
Free Cash Flow
1 |
-46.5
|
191
|
-210
|
-866
|
-826
|
-3,598
|
ROE (net income / shareholders' equity)
|
4.74%
|
5.31%
|
10.3%
|
10.2%
|
12.3%
|
-4.22%
|
ROA (Net income/ Total Assets)
|
2.75%
|
3.4%
|
3.89%
|
3.94%
|
4.98%
|
-1.15%
|
Assets
1 |
1,948
|
1,617
|
14,380
|
15,998
|
16,439
|
24,012
|
Book Value Per Share
2 |
1.640
|
1.680
|
1.570
|
1.670
|
1.730
|
1.620
|
Cash Flow per Share
2 |
1.270
|
1.480
|
1.250
|
0.4100
|
0.5800
|
0.5400
|
Capex
1 |
29.6
|
3.74
|
475
|
661
|
1,479
|
1,136
|
Capex / Sales
|
2.5%
|
0.36%
|
2.92%
|
3.4%
|
6.48%
|
4.84%
|
Announcement Date
|
4/22/19
|
3/9/20
|
4/19/21
|
3/28/22
|
3/28/23
|
3/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -18.60% | 1.06B | | -1.96% | 74.28B | | +0.05% | 46.91B | | +2.38% | 32.93B | | +7.54% | 17.78B | | -6.58% | 12.09B | | +12.48% | 11.88B | | -0.23% | 10.66B | | +3.37% | 9.55B | | +5.01% | 8.28B |
Diversified Chemicals
|